TW201838701A - Method for controlling injection of flocculant, control device, and water treatment system - Google Patents

Method for controlling injection of flocculant, control device, and water treatment system Download PDF

Info

Publication number
TW201838701A
TW201838701A TW106132882A TW106132882A TW201838701A TW 201838701 A TW201838701 A TW 201838701A TW 106132882 A TW106132882 A TW 106132882A TW 106132882 A TW106132882 A TW 106132882A TW 201838701 A TW201838701 A TW 201838701A
Authority
TW
Taiwan
Prior art keywords
water
aggregating agent
value
flow potential
amount
Prior art date
Application number
TW106132882A
Other languages
Chinese (zh)
Inventor
藤井昭宏
Original Assignee
日商栗田工業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商栗田工業股份有限公司 filed Critical 日商栗田工業股份有限公司
Publication of TW201838701A publication Critical patent/TW201838701A/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D21/00Separation of suspended solid particles from liquids by sedimentation
    • B01D21/30Control equipment
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/52Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/52Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
    • C02F1/54Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities using organic material
    • C02F1/56Macromolecular compounds
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/72Treatment of water, waste water, or sewage by oxidation
    • C02F1/76Treatment of water, waste water, or sewage by oxidation with halogens or compounds of halogens

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hydrology & Water Resources (AREA)
  • Engineering & Computer Science (AREA)
  • Environmental & Geological Engineering (AREA)
  • Water Supply & Treatment (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Treatment Of Water By Oxidation Or Reduction (AREA)

Abstract

A method for controlling the injection of a flocculant in a water treatment system in which a cationic polymer flocculant and an inorganic flocculant are added to treatment water and solid-liquid separation is performed, wherein the method for controlling the injection of a flocculant is characterized in that: the flow potential of the treatment water, or of flocculant-treated water to which a flocculant has been added, is measured; the addition amounts of the cationic polymer flocculant and the inorganic flocculant are determined on the basis of the measured flow potential; and the cationic polymer flocculant and the inorganic flocculant are added in the determined amounts.

Description

凝集劑注入控制方法、控制裝置及水處理系統Aggregate injection control method, control device and water treatment system

[0001] 本發明係關於當將各種產業排水或工業用水等進行凝集處理時之用以決定陽離子性高分子及無機凝集劑的最適凝集劑量的控制方法及裝置。此外,本發明係關於具有該控制裝置的水處理系統。[0001] The present invention relates to a method and apparatus for controlling an optimum agglutination amount of a cationic polymer and an inorganic aggregating agent when aggregating various industrial drainage or industrial water or the like. Furthermore, the invention relates to a water treatment system having such a control device.

[0002] 在各種排水/用水的前處理中,使用凝集處理,俾以去除濁質及有機物。以凝集處理所使用的凝集劑而言,一般使用氯化鐵或聚氯化鋁等鐵系凝集劑或鋁系無機凝集劑,但是亦進行將陽離子性高分子凝集劑與無機凝集劑併用的凝集處理。藉由使用如此2種藥品,除了產生凝集團粒粗大化且容易進行後段的固液分離操作之外,可達成因抑制無機凝集劑的添加量所致之污泥發生量的削減(專利文獻1、2)。   [0003] 凝集劑的添加量係必須依被處理水的水質來添加適當的量。若藥品量不足,被處理水中所含有的濁質或有機物的去除變得不充分,發生處理水質惡化。另一方面,若藥品量過剩,藥品漏洩至後段,有引起在後段處理的負荷增大或污染的可能性。   [0004] 為決定最適藥品量,一般進行瓶杯試驗,但是需要龐大勞力,每逢被處理水的水質變動即進行瓶杯試驗,在實際的水處理中,無法即時對應變動,並不實際。在凝集劑注入量的自動控制中,進行根據被處理水的特定水質,例如濁度或有機物濃度等的控制(專利文獻3、4)。此外,已有報告提出以凝集處理水的流動電流計的值為指標,來控制凝集劑注入量的方法(專利文獻5)。   [0005] 凝集反應一般係藉由利用凝集劑所致之荷電中和予以促進,因此以利用根據利用流動電位(流動電流)及Zeta電位等的界面動電現象的測定,與著重在特定的水質項目的控制相比,可期待為相對於以更大範圍為對象的被處理水,可較為適用控制者。   [0006]   [專利文獻1]日本專利第2938270號   [專利文獻2]日本專利第6028826號   [專利文獻3]日本專利第4746385號   [專利文獻4]日本專利第5103747號   [專利文獻5]日本專利第5349378號   [0007] 在專利文獻1~3的控制中,予以添加量控制的藥品侷限於1種,在併用陽離子性高分子凝集劑與無機凝集劑的2種類藥品的二劑添加處理中,並無法算出至各藥品的最適添加量。[0002] In various pretreatments of drainage/water, an agglutination treatment is used to remove turbidity and organic matter. In the aggregating agent used for the agglutination treatment, an iron-based aggregating agent such as ferric chloride or polyaluminum chloride or an aluminum-based inorganic aggregating agent is generally used, but agglomeration using a cationic polymer flocculating agent and an inorganic aggregating agent is also performed. deal with. By using these two kinds of chemicals, in addition to the coarsening of the aggregates and the easy completion of the solid-liquid separation operation in the latter stage, the amount of sludge generated by suppressing the addition amount of the inorganic flocculant can be reduced (Patent Document 1) 2). [0003] The amount of the aggregating agent to be added must be added in an appropriate amount depending on the quality of the water to be treated. If the amount of the drug is insufficient, the removal of the turbid substance or the organic substance contained in the water to be treated becomes insufficient, and the treated water quality deteriorates. On the other hand, if the amount of the drug is excessive, the drug leaks to the subsequent stage, and there is a possibility that the load to be treated in the latter stage is increased or contaminated. [0004] In order to determine the optimum amount of medicine, the bottle test is generally carried out, but it requires a large amount of labor. When the water quality of the water to be treated is changed, the bottle test is performed, and in actual water treatment, it is not practical to respond to the change immediately. In the automatic control of the amount of the aggregating agent to be injected, control is performed based on the specific water quality of the water to be treated, such as turbidity or organic matter concentration (Patent Documents 3 and 4). In addition, a method of controlling the amount of aggregating agent injection by using the value of the flow current meter of the agglomerated water is proposed (Patent Document 5). [0005] The agglutination reaction is generally promoted by the charge neutralization by the use of a coagulant, and therefore, the measurement is based on the use of an interface electrokinetic phenomenon using a flow potential (flow current) and a zeta potential, and is focused on a specific water quality. Compared with the control of the project, it is expected that the controller can be applied to the treated water for a larger range. [Patent Document 1] Japanese Patent No. 2,938, 270 [Patent Document 2] Japanese Patent No. 6028826 [Patent Document 3] Japanese Patent No. 4746835 [Patent Document 4] Japanese Patent No. 5103747 [Patent Document 5] Japanese Patent In the control of Patent Documents 1 to 3, the drug to be added in an amount-controlled manner is limited to one type, and in the two-agent addition treatment of two types of drugs using a cationic polymer flocculating agent and an inorganic aggregating agent in combination, It is not possible to calculate the optimum amount of each drug to be added.

(發明所欲解決之課題)   [0008] 本發明之目的在提供在對被處理水,添加陽離子性高分子及無機凝集劑的2種類藥品作為凝集劑的系統(二劑添加處理)中,將2種類的藥品添加量分別適當控制的方法及裝置。 (解決課題之手段)   [0009] 本發明之要旨如下。   [0010] [1] 一種凝集劑注入控制方法,其係在被處理水添加陽離子性高分子凝集劑及無機凝集劑,且進行固液分離的水處理系統中的凝集劑注入控制方法,其特徵為:   測定被處理水、或添加有凝集劑的凝集處理水的流動電位,根據所測定出的流動電位值,求出上述陽離子性高分子凝集劑及無機凝集劑的添加量,且以該添加量添加陽離子性高分子凝集劑及無機凝集劑。   [0011] [2] 如[1]之凝集劑注入控制方法,其中,藉由事前試驗,由凝集處理水的流動電位值的最適值與實際的凝集處理水的流動電位值的差,求出無機凝集劑的不足濃度A,   將無機凝集劑的添加量設為a・A,該陽離子性高分子凝集劑的添加量設為b・A,   其中,a=0.1~0.9   b=0.001~0.008。   [0012] [3] 如[2]之凝集劑注入控制方法,其中,為了補正所被測定出的凝集處理水的流動電位值的誤差,在凝集處理水的流動電位值的測定前或後,測定標準溶液的流動電位,根據標準溶液的流動電位值,補正實際的凝集處理水的流動電位值而得補正值,且由凝集處理水的流動電位值的最適值與補正值的差,算出無機凝集劑的不足濃度A。。   [0013] [4] 如[3]之凝集劑注入控制方法,其中,以下式進行補正。   [0014]   E2=E1×(R2/R1)   其中,E1:凝集處理水的流動電位值(實測值)[mV]   E2:凝集處理水的流動電位值(補正值)[mV]   R1:標準液的流動電位值(事前的工作台試驗評估時)[mV]   R2:標準液的流動電位值(凝集處理水的流動電位測定前或後)[mV]   [0015] [5] 如[1]之凝集劑注入控制方法,其中,將凝集處理水的一部分在測定容器進行取樣來測定流動電位,   藉由滴定,計測所被測定出的流動電位值由負至顯示0的值為止所需的陽離子性高分子凝集劑的添加量B,   將陽離子性高分子凝集劑的追加添加量設為c・B,無機凝集劑的追加添加量設為d・B,   其中,c=0.1~0.9   d=5~90。   [0016] [6] 如[1]之凝集劑注入控制方法,其中,將被處理水在測定容器進行取樣,   藉由滴定,計測所被測定出的流動電位值由負至顯示0的值為止所需的陽離子性高分子凝集劑的添加量C,   將陽離子性高分子凝集劑的添加量設為e・C,無機凝集劑的添加量設為f・C,   其中,e=0.1~0.9   f=5~90。   [0017] [7] 一種凝集劑注入控制裝置,其係在被處理水添加陽離子性高分子凝集劑及無機凝集劑,且進行固液分離的水處理系統中的凝集劑注入控制裝置,其特徵為:   具有:   測定被處理水、或添加有凝集劑的凝集處理水的流動電位的流動電位計;及   根據該流動電位計的計測值,分別求出上述陽離子性高分子凝集劑及無機凝集劑的添加量的算出手段。   [0018] [8] 如[7]之凝集劑注入控制裝置,其中,前述算出手段具有:   由藉由事前試驗所求出的凝集處理水的流動電位值的最適值與控制流動電位的測定值的差,求出無機凝集劑的不足濃度A的手段;及   將無機凝集劑的添加量設為a・A,該陽離子性高分子凝集劑的添加量設為b・A的手段。   [0019] [9] 如[8]之凝集劑注入控制裝置,其中,前述算出手段係具有:   在凝集處理水的流動電位值的測定前或後,測定標準溶液的流動電位的測定手段;   根據標準溶液的流動電位值,獲得所被測定出的凝集處理水的流動電位值的補正值的手段;及   由凝集處理水的流動電位值的最適值與補正值的差,算出無機凝集劑的不足濃度A的手段。   [0020] [10] 如[7]之凝集劑注入控制裝置,其中,具備有:   收容凝集處理水的一部分的測定容器;   被設在該測定容器的前述流動電位計;   藉由滴定,計測該流動電位計的計測值由負至顯示0的值為止所需的陽離子性高分子凝集劑的添加量的手段;及   算出該陽離子性高分子凝集劑的追加添加量為c・B,且算出無機凝集劑的追加添加量為d・B的手段,   其中,c=0.1~0.9   d=5~90。   [0021] [11] 如[7]之凝集劑注入控制裝置,其中,具備有:   收容被處理水的一部分的測定容器;   被設在該測定容器的前述流動電位計;   藉由滴定,計測該流動電位計的計測值由負至顯示0的值為止所需的該陽離子性高分子的添加量C的手段;及   算出陽離子性高分子凝集劑的添加量為e・C,且算出無機凝集劑的添加量為f・C的手段,   其中,e=0.1~0.9   f=5~90。   [0022] [12] 如[7]~[11]中任一者之凝集劑注入控制裝置,其中,具備有用以計測凝集處理水中的凝集團粒間的空隙中的濁度的光散射式微粒子感測器或光遮斷式微粒子感測器。   [0023] [13] 一種水處理系統,其係具有如[7]~[12]中任一者之凝集劑注入控制裝置的水處理系統,其特徵為:   具有:將凝集處理水進行固液分離的固液分離手段。   [0024] [14] 如[13]之水處理系統,其中,具有:被處理水的ORP值的測定手段;及以被處理水的ORP值成為300mV以上的方式,對被處理水添加氧化劑的添加手段。 (發明之效果)   [0025] 藉由本發明,在對被處理水添加陽離子性高分子凝集劑及無機凝集劑的2種類凝集劑的二劑添加處理中,即使在發生被處理水的水質變動的情形下,亦可算出各凝集劑的適當添加量,防止因凝集不良所致之後段處理的污染。(Problem to be Solved by the Invention) [0008] An object of the present invention is to provide a system (two-agent addition treatment) in which two kinds of drugs, which are a cationic polymer and an inorganic aggregating agent, are added as a coagulant to a water to be treated, A method and apparatus for appropriately controlling the amount of two types of medicines to be separately controlled. (Means for Solving the Problem) [0009] The gist of the present invention is as follows. [1] A method for controlling aggregating agent injection, which is a method for controlling aggregating agent injection in a water treatment system in which a cationic polymer aggregating agent and an inorganic aggregating agent are added to a treated water, and solid-liquid separation is performed, and the characteristics thereof are characterized. The flow potential of the water to be treated or the agglomerated water to which the aggregating agent is added is measured, and the amount of the cationic polymer flocculating agent and the inorganic aggregating agent added is determined based on the measured flow potential value, and the addition amount is obtained by the addition. A cationic polymer flocculant and an inorganic aggregating agent are added in an amount. [2] The method for controlling aggregating agent injection according to [1], wherein the difference between the optimum value of the flow potential value of the agglomerated water and the flow potential value of the actual agglomerated water is obtained by a prior test. Insufficient concentration A of the inorganic aggregating agent, the amount of the inorganic aggregating agent added is a·A, and the amount of the cationic polymer aggregating agent added is b·A, where a=0.1 to 0.9 b=0.001 to 0.008. [3] The agglutination agent injection control method according to [2], wherein, in order to correct an error of a flow potential value of the aggregated treated water to be measured, before or after the measurement of the flow potential value of the aggregated treated water, The flow potential of the standard solution is measured, and the flow potential value of the actual agglutination treatment water is corrected according to the flow potential value of the standard solution to obtain a correction value, and the difference between the optimum value of the flow potential value of the agglutination treatment water and the correction value is calculated. Insufficient concentration A of the aggregating agent. . [4] The method for controlling aggregating agent injection according to [3], wherein the following formula is corrected. E2=E1×(R2/R1) where E1: the flow potential value of the agglutination treatment water (measured value) [mV] E2: the flow potential value of the agglutination treatment water (correction value) [mV] R1: standard solution The value of the flow potential (at the time of the bench test evaluation) [mV] R2: The flow potential value of the standard solution (before or after the measurement of the flow potential of the agglutination treatment water) [mV] [0015] [5] As in [1] The agglutination agent injection control method is characterized in that a part of the agglutination-treated water is sampled in a measurement container to measure a flow potential, and a titration is performed to measure a cationicity required for the measured flow potential value to be negative until a value of 0 is displayed. The addition amount B of the polymer aggregating agent is c·B, and the additional addition amount of the inorganic aggregating agent is d·B, wherein c=0.1 to 0.9 d=5 ~ 90. [6] The aggregating agent injection control method according to [1], wherein the water to be treated is sampled in the measurement container, and the measured flow potential value is measured by titration until the value of 0 is displayed. The amount C of the cationic polymer flocculating agent required is set to e·C, and the amount of the inorganic aggregating agent is f·C, where e=0.1 to 0.9 f =5 to 90. [7] A flocculant injection control device which is a flocculant injection control device in a water treatment system in which a cationic polymer aggregating agent and an inorganic aggregating agent are added to a treated water and subjected to solid-liquid separation, and is characterized by And a flow potentiometer for measuring a flow potential of the water to be treated or the agglomerated water to which the aggregating agent is added; and determining the cationic polymer aggregating agent and the inorganic aggregating agent based on the measured value of the flow potentiometer The means of calculating the amount of addition. [8] The aggregating agent injection control device according to [7], wherein the calculation means includes: an optimum value of a flow potential value of the aggregated treated water obtained by a prior test, and a measured value of the control flow potential The difference is the means for determining the insufficient concentration A of the inorganic aggregating agent; and the means for adding the inorganic aggregating agent to a·A, and the amount of the cationic polymer aggregating agent to be added is b·A. [9] The aggregating agent injection control device according to [8], wherein the calculating means includes: a measuring means for measuring a flow potential of the standard solution before or after the measurement of the flow potential value of the agglomerated water; a means for obtaining a correction value of the flow potential value of the agglutination treatment water to be measured, and a difference between the optimum value of the flow potential value of the agglutination treatment water and the correction value, and calculating the deficiency of the inorganic aggregating agent The means of concentration A. [10] The aggregating agent injection control device according to [7], further comprising: a measurement container that houses a part of the agglutination water; a flow potentiometer provided in the measurement container; and the measurement is performed by titration The means for calculating the amount of the cationic polymer flocculating agent required for the measurement of the flow potentiometer from the negative to the value of 0; and calculating the additional amount of the cationic polymer flocculating agent to be c·B, and calculating the inorganic The additional amount of the aggregating agent is a means of d·B, wherein c = 0.1 to 0.9 d = 5 to 90. [11] The aggregating agent injection control device according to [7], further comprising: a measurement container that accommodates a part of the water to be treated; the flow potentiometer provided in the measurement container; and the measurement by titration The measurement value of the flow potentiometer is a means for reducing the amount C of the cationic polymer required until the value of 0 is displayed; and the amount of addition of the cationic polymer flocculating agent is calculated as e·C, and the inorganic aggregating agent is calculated. The amount of addition is f·C, where e=0.1 to 0.9 f=5 to 90. [12] The aggregating agent injection control device according to any one of [7] to [11], wherein the light scattering type fine particle sensation is provided to measure turbidity in a void between the coagulated particles in the agglutination treatment water. Detector or light-interrupting particle sensor. [13] A water treatment system comprising the aggregating agent injection control device according to any one of [7] to [12], wherein: the method comprises: performing a solid-liquid treatment of the agglutination treatment water Separation of solid-liquid separation means. [14] The water treatment system according to [13], wherein: the method for measuring an ORP value of the water to be treated; and the method of adding an oxidizing agent to the water to be treated so that the ORP value of the water to be treated is 300 mV or more Add means. (Effect of the Invention) According to the present invention, in the two-agent addition treatment of two types of aggregating agents in which a cationic polymer flocculating agent and an inorganic aggregating agent are added to the water to be treated, even if the water quality of the water to be treated is changed, In this case, an appropriate addition amount of each aggregating agent can also be calculated to prevent contamination of the subsequent stage treatment due to poor aggregation.

[0027] 以下參照圖示,說明實施形態。   [0028] 圖1係顯示第1實施形態之控制裝置的構成圖。原水係被導入至原水槽1,若有需要,藉由被配備在原水槽1的ORP計2及原水槽藥品注入控制裝置4,以ORP成為300mV以上的方式添加氧化劑。以氧化劑而言,可使用次氯酸鹽或二氧化氯化合物。   [0029] 若在凝集劑添加前必須將pH調整為一定時,亦可採取在原水槽1設置pH計3,且在原水槽1的前段設置pH調整槽1a的形態。以pH調整劑而言,可使用氫氧化鈉、消石灰、鹽酸、硫酸等。   [0030] 原水槽1內的原水係接著被導入至凝集槽5,一部分被導入至取樣槽(sampling cell)6。在取樣槽6中,被封入一定體積的原水,藉由滴定裝置7進行藉由陽離子性高分子凝集劑溶液所為之滴定,藉此可計測流動電位計8的計測值由負至顯示0的值為止所需的陽離子性高分子凝集劑的濃度(添加量)。其中,以採用在進行滴定之前,以一定時間將原水通水至取樣槽6之後,以安裝在取樣槽6的原水側的閥9暫時停止流通的截流(Stopped flow)方式為宜。   [0031] 滴定所使用的陽離子性高分子凝集劑係以使用與作為凝集劑所使用的陽離子性高分子凝集劑為相同者為宜。   [0032] 以可將流動電位計8的測定部及取樣槽6內定期洗淨的方式,以可在取樣槽6導入洗淨液為宜。以洗淨液而言,以依被處理水的水質,使用酸、鹼、氧化劑的1種或2種以上為宜。   [0033] 在凝集槽5中,除了陽離子性高分子凝集劑及無機凝集劑的2種類藥品之外,藉由凝集劑注入控制裝置10添加用以將凝集處理水的pH調整為一定的pH調整劑。   [0034] 以所使用的陽離子性高分子凝集劑而言,列舉:聚(二烯丙基二甲基銨氯化物)、聚(甲基丙烯酸2-二甲基胺基乙基酯)、聚甲基丙烯酸二甲基胺基乙酯氯化苄基四級鹽、聚伸乙亞胺、聚烯丙基胺、聚乙烯基胺、聚(甲基丙烯酸2-二甲基胺基乙基酯)、聚(2-乙烯基-1-甲基吡啶鎓)、二烷基胺-環氧氯丙烷縮聚物、聚離胺酸、幾丁聚醣、二乙基胺基乙基聚葡萄醣等。以無機凝集劑而言,列舉:三氯化鐵、硫酸鐵、聚三氯化鐵、聚硫酸鐵等鐵系無機凝集劑或氯化鋁、聚氯化鋁、硫酸鋁、氫氧化鋁、氧化鋁等鋁系無機凝集劑。亦可使用2種類以上的陽離子性高分子凝集劑的混合物作為凝集劑,亦可使用2種類以上的無機凝集劑的混合物作為無機凝集劑。   [0035] 陽離子性高分子凝集劑及無機凝集劑的添加量係由藉由前述滴定所求出的陽離子性高分子凝集劑的濃度予以算出(詳容後述)。陽離子性高分子凝集劑與無機凝集劑係如圖所示亦可添加在個別的凝集槽5、11,亦可雖省略圖示而添加在同一凝集槽。關於添加順序,可將任一者先添加,亦可同時添加。   [0036] 以在pH計12被檢測出的凝集槽11內的pH成為預定pH的方式添加pH調整劑。   [0037] 凝集槽5內的凝集處理水係接著被導入至凝集感測器槽13。凝集感測器槽13係具備有:微粒子感測器14。以微粒子感測器14而言,可使用具備有:用以測定凝集團粒的空隙的濁度、且用以放射雷射光的發光器、及用以檢測散射的雷射光的探針的光散射式微粒子感測器(例如日本專利第3925621號所記載者等)或光遮斷式微粒子感測器等。   [0038] 若在微粒子感測器14被計測到的凝集團粒的空隙的濁度上升,被認為因相對於水質變動之凝集劑二劑的添加量的不足或過剩、或陽離子性高分子凝集劑與無機凝集劑的添加量的比率不適當時的某些理由而發生凝集不良。   [0039] 根據流動電位計8的計測值的凝集劑添加量的自動調節亦可以定期間隔實施的方式進行設定,或者/而且可以在微粒子感測器14所計測到的凝集團粒的空隙的濁度上升時實施的方式進行設定。   [0040] 凝集感測器槽13內的凝集處理水係透過處理水泵15而被送水至固液分離處理設備。以固液分離處理而言,列舉:膜分離處理、砂過濾處理、沈澱處理、加壓浮上處理。   [0041] 由以流動電位計8所求出的滴定值,分別算出陽離子性高分子凝集劑及無機凝集劑的添加量的方法係可由例如圖2所示之結果來求出。   [0042] 圖2係顯示陽離子性高分子凝集劑的添加濃度與流動電位值的關係之一例的滴定曲線。例如,荷電中和所需的滴定量(C)係流動電位值達至0mV時的陽離子性高分子凝集劑的添加濃度(在此為約5mg/L)。   [0043] 無機凝集劑的添加量雖亦取決於被處理水的水質及所使用的無機凝集劑的種類,惟以比C為較多,較佳為成為C的5~90倍(亦即C×5~C×90),尤其10~50倍的範圍內的方式進行調整設定為宜。陽離子性高分子凝集劑的添加量雖亦取決於被處理水的水質及所使用的陽離子性高分子凝集劑的種類,惟以比C為較少,較佳為成為C的0.1~0.9倍(亦即C×0.1~C×0.9),尤其0.5~0.9倍的範圍內的方式進行調整設定為宜。   [0044] 圖3係本發明之其他實施形態之凝集劑注入控制裝置的構成的概略圖。   [0045] 圖3的控制裝置係將圖1的前饋控制變更為反饋控制者。亦即,取樣槽6係收容來自凝集感測器槽13的凝集處理水的一部分,以將測定後的水送回至凝集感測器槽13的方式予以設置。   [0046] 在該取樣槽6係設有流動電位計8。藉由使用與前述同樣的陽離子性高分子凝集劑的滴定,可計測離現在的藥品注入量不足的不足份的凝集劑量。其中,取樣槽6係可設置為導入來自凝集槽11的凝集處理水,亦可設置在固液分離裝置的後段來導入固液分離處理水。   [0047] 從由流動電位計8所得的荷電中和所需的滴定量(B),無機凝集劑的追加添加量雖亦取決於被處理水的水質及所使用的無機凝集劑的種類,惟以比B為較多,較佳為成為B的5~90倍(亦即B×5~B×90),較佳為B的10~50倍的範圍內的方式進行調整設定為宜。此外,陽離子性高分子凝集劑的追加添加量雖亦取決於被處理水的水質及所使用的陽離子性高分子凝集劑的種類,惟以比B為較少,較佳為成為B的0.1~0.9倍(亦即B×0.1~B×0.9),較佳為B的0.5~0.9倍的範圍內的方式進行調整設定為宜。   [0048] 雖亦取決於被處理水的水質,若B的滴定值為未達0.1mg/L時,係以將陽離子性高分子凝集劑與無機凝集劑的添加量分別以5%以下的範圍削減的方式進行設定為宜。   [0049] 圖4係顯示另外其他實施形態之控制裝置。圖4的控制裝置係由圖3的構成中不要在取樣槽6的滴定裝置者,必須藉由事前評估來求出凝集處理水的流動電位值的最適值。在圖4中,與圖3同樣地,取樣槽6係以由凝集感測器槽13收容凝集處理水的方式予以設置,惟與圖3的情形同樣地,取樣槽6亦可由凝集槽11導入凝集處理水,亦可設置在固液分離裝置的後段來導入固液分離處理水。其中,若導入固液分離處理水,必須藉由事前評估來求出固液分離處理水的流動電位值的最適值。   [0050] 凝集處理水的流動電位值的最適值係可由例如圖5所示結果,來求出最適值。   [0051] 圖5係顯示以事前的工作台試驗進行評估之無機凝集劑添加量與流動電位值、凝集處理水水質的關係,凝集處理水水質係以MFF值表示。   [0052] MFF值的測定方法係如下所示。將MF膜設定在吸引過濾裝置,在-67kPa的減壓下測定出溶解性高分子物質及無微粒子的基準水150mL的透過時間T0後,測定測定試料(150mL)的第1次通水時間T1、第2次通水時間T2。MFF值=T2/T1。   [0053] MFF的值成為良好時,流動電位係顯示特定的值,該值為凝集處理水的流動電位值的最適值(在此為約 -300mV)。將如上所示之無機凝集劑添加量與流動電位值的相關圖記錄在凝集控制裝置,由實際的凝集處理水的流動電位值所示之無機凝集劑濃度與流動電位值成為最適值的無機凝集劑濃度(在此為約200mg/L)的差,算出無機凝集劑的不足濃度(A)。   [0054] 無機凝集劑的追加添加量亦取決於被處理水的水質及所使用的無機凝集劑的種類,惟以成為A的0.1~0.9倍(亦即A×0.1~A×0.9),較佳為A的0.2~0.5倍的範圍內的方式進行調整設定為宜。此外,陽離子性高分子凝集劑的追加添加量亦取決於被處理水的水質及所使用的陽離子性高分子凝集劑的種類,惟以成為A的0.001~0.008倍(亦即A×0.001~A×0.008),較佳為A的0.005~0.008倍的範圍內的方式進行調整設定為宜。   [0055] 若實際的凝集處理水的流動電位值比凝集處理水的流動電位值的最適值為更高時,陽離子性高分子凝集劑成為過剩的可能性高,因此必須進行凝集劑添加量的設定值的重新評估。   [0056] 圖4的構成中的流動電位計8的線上計測中的問題點在於因被處理水中所含有的濁質或有機物、所添加的凝集劑等,流動電位計8的測定部髒污而無法正確計測流動電位值的絕對值。雖然亦考慮每次測定即進行洗淨的方法,但是會新發生洗淨液的消耗量增大、洗淨期間無法進行計測等問題。   [0057] 為解決該問題,以下顯示測定標準液的流動電位值且將實測值補正的手法。以標準液而言,為使其具有電導性,可使用在將低濃度的鹽或pH緩衝劑溶解的溶液,添加有聚苯乙烯乳膠粒子或矽石粒子等的分散液。粒子的大小係以粒子徑數百nm以下的膠體粒子為宜,俾以不會發生粒子沈積。   [0058] 供補正用的換算式係如以下所示。   E2=E1×(R2/R1)   E1:凝集處理水的流動電位值(實測值)[mV]   E2:凝集處理水的流動電位值(補正值)[mV]   R1:標準液的流動電位值(事前的工作台試驗評估時)[mV]   R2:標準液的流動電位值(凝集處理水的流動電位測定前或後)[mV] [實施例]   [0059] <試驗方法>   在以下之實施例及比較例中使用的試驗被處理水、試藥係如以下所示。   試驗被處理水:工廠排水的生物處理水(ORP:100~200mV)   陽離子性高分子:聚(二烯丙基二甲基銨氯化物)   無機凝集劑:三氯化鐵(38%)   氧化劑:次氯酸鈉   [0060] [實施例1]   以圖1所示之凝集劑注入控制系統的構成,以原水槽的ORP在325±25mV的範圍內的方式,對原水槽添加氧化劑,凝集劑添加量的自動調節值的設定係形成為:   陽離子性高分子:C×0.8[mg/L]   無機凝集劑:C×8[mg/L]   來進行凝集處理。測定出所得的凝集處理水的MFF值的經時變化。   [0061] [比較例1]   以圖1所示之系統構成,不進行凝集劑添加量的自動調節,而將陽離子性高分子的添加量形成為0.5mg/L、無機凝集劑的添加量形成為50mg/L的定量注入。其他係與實施例1相同。   [0062] 將實施例1及比較例1的結果顯示在圖6。依因時間經過所致之被處理水的水質變動,滴定量C值亦同樣地變動,在比較例1中,連同水質變動,凝集處理水質一起惡化。另一方面,在實施例1中係以C值為基準而將2種類的凝集劑添加量自動調節,藉此幾乎未發現凝集處理水質惡化,而且未發生變動。   [0063] [實施例2]   以圖1所示之系統構成,以原水槽的ORP在325±25mV的範圍內的方式,對原水槽添加氧化劑,且凝集劑添加量的自動調節值的設定係形成為:   陽離子性高分子:C×0.2[mg/L]   無機凝集劑:C×30[mg/L]   來進行凝集處理。   此外,進行膜分離處理(PVDF、孔徑0.02μm、運轉條件:運轉Flux(流通量)4m/D、逆洗間隔28min),作為系統後段的固液分離處理,來測定膜間差壓的上升速度。   [0064] [比較例2]   以圖1所示之系統構成,對原水槽未添加氧化劑,進行凝集處理。其他與實施例2相同。   [0065] 將實施例2及比較例2的結果顯示於表1。在實施例2中係藉由對原水槽添加氧化劑,C值比比較例2更為降低。此被認為因被處理水的氧化所致之改質所致者。此外,差壓上升速度係以實施例2為較低,可知獲得良好的凝集處理水。由此清楚可知即使使用流動電位計來自動調節二種類的劑的添加量,若原水槽的ORP未被調節至一定值以上,亦無法充分進行凝集控制。   [0066] [表1] [0067] [實施例3]   以圖1所示之系統構成,進行膜分離處理(PVDF、孔徑0.02μm、運轉條件:運轉Flux2~4m/D、逆洗間隔10~28min),作為系統後段的固液分離處理。此外,藉由被配備在凝集感測器槽的光散射式微粒子感測器,測定出連續通水中的凝集處理水中的凝集團粒的空隙的濁度(團粒間濁度)與膜間差壓的上升速度的關係。   [0068] 將結果顯示於圖7。可知若團粒間濁度上升,差壓上升速度亦變高,發現強相關。團粒間濁度的上升係被認為原因在於:被處理水的水質急遽變動而發生凝集不良、或者被處理水的水質極為大幅變動,相對於以流動電位計所測定出的值(A、B、C的值)之2種類的凝集劑的自動添加量的調整設定不適當。   [0069] 因此,考慮:當團粒間濁度上升至一定值以上時,以進行藉由流動電位計的計測所為之凝集劑添加量的自動調節的方式進行設定的方法、或將2種類的凝集劑的自動添加量的調整設定重新設定為新的值的方法。如上所示,可作為藉由被配備在凝集感測器槽的粒子感測器,確認是否發生凝集不良的警報感測器加以利用。   [0070] 以上使用特定的態樣,詳細說明本發明,惟可在未脫離本發明之意圖與範圍的情形下進行各種變更,為該領域熟習該項技術者清楚可知。   本申請案係根據2017年3月13日所申請之日本專利申請案2017-047570,藉由引用而沿用其全體。[0027] Hereinafter, embodiments will be described with reference to the drawings. 1 is a configuration diagram showing a control device according to a first embodiment. The raw water is introduced into the raw water tank 1 and, if necessary, the oxidizing agent is added so that the ORP is 300 mV or more by the ORP meter 2 and the raw water tank medicine injection control device 4 provided in the raw water tank 1. As the oxidizing agent, a hypochlorite or a chlorine dioxide compound can be used. [0029] When the pH must be adjusted to be constant before the addition of the aggregating agent, the pH meter 3 may be provided in the raw water tank 1, and the pH adjusting tank 1a may be provided in the front stage of the raw water tank 1. As the pH adjuster, sodium hydroxide, slaked lime, hydrochloric acid, sulfuric acid or the like can be used. [0030] The raw water system in the raw water tank 1 is then introduced into the condensation tank 5, and a part thereof is introduced into a sampling cell 6. In the sampling tank 6, a predetermined volume of raw water is sealed, and the titration device 7 performs titration by the cationic polymer flocculant solution, whereby the measured value of the flow potentiometer 8 can be measured from negative to a value of 0. The concentration (addition amount) of the cationic polymer flocculant required until then. In the above, it is preferable to use a stopped flow method in which the valve 9 attached to the raw water side of the sampling tank 6 is temporarily stopped after the raw water is passed through the sampling tank 6 for a predetermined period of time before the titration is performed. The cationic polymer flocculating agent used for the titration is preferably the same as the cationic polymer aggregating agent used as the aggregating agent. [0032] It is preferable to introduce the cleaning liquid into the sampling tank 6 so that the measuring portion of the flow potentiometer 8 and the sampling tank 6 can be periodically washed. In the case of the washing liquid, one or two or more kinds of an acid, a base, and an oxidizing agent are preferably used depending on the water quality of the water to be treated. In the coagulation tank 5, in addition to the two types of the cationic polymer flocculating agent and the inorganic aggregating agent, a pH adjustment for adjusting the pH of the agglutination water to be constant is added by the coagulant injection control device 10. Agent. [0034] Examples of the cationic polymer flocculating agent used include poly(diallyldimethylammonium chloride), poly(2-dimethylaminoethyl methacrylate), and poly Dimethylaminoethyl methacrylate benzyl quaternary salt, polyethylenimine, polyallylamine, polyvinylamine, poly(2-dimethylaminoethyl methacrylate) ), poly(2-vinyl-1-methylpyridinium), dialkylamine-epichlorohydrin polycondensate, polylysine, chitosan, diethylaminoethylpolydextrose, and the like. Examples of the inorganic aggregating agent include iron-based inorganic aggregating agents such as ferric chloride, ferric sulfate, polyferric chloride, and polyferric sulfate; or aluminum chloride, polyaluminum chloride, aluminum sulfate, aluminum hydroxide, and oxidation. Aluminum-based inorganic aggregating agent such as aluminum. A mixture of two or more types of cationic polymer flocculating agents may be used as the aggregating agent, or a mixture of two or more types of inorganic aggregating agents may be used as the inorganic aggregating agent. The addition amount of the cationic polymer flocculating agent and the inorganic aggregating agent is calculated from the concentration of the cationic polymer flocculating agent determined by the above-described titration (details will be described later). The cationic polymer flocculating agent and the inorganic aggregating agent may be added to the individual aggregation tanks 5 and 11 as shown in the drawing, or may be added to the same aggregation tank although not shown. Regarding the order of addition, either one may be added first or both. [0036] The pH adjuster is added so that the pH in the aggregation tank 11 detected by the pH meter 12 becomes a predetermined pH. [0037] The agglutination treatment water in the aggregating tank 5 is then introduced into the agglutination sensor tank 13. The aggregating sensor tank 13 is provided with a fine particle sensor 14. In the microparticle sensor 14, a light scattering type including an illuminator for measuring the turbidity of the condensed particles, an illuminator for radiating the laser light, and a probe for detecting the scattered laser light can be used. A microparticle sensor (for example, those described in Japanese Patent No. 3925621) or a photo-interrupting microparticle sensor or the like. [0038] If the turbidity of the voids of the agglomerated particles measured by the fine particle sensor 14 is increased, it is considered that the amount of the addition of the two agents of the aggregating agent with respect to the water quality is insufficient or excessive, or the cationic polymer aggregating agent The agglutination failure occurs for some reason that the ratio of the amount of the inorganic aggregating agent added is inappropriate. The automatic adjustment of the amount of the aggregating agent added according to the measured value of the flow potentiometer 8 may be set at a time interval, or/and the turbidity of the void of the condensed group particles measured by the microparticle sensor 14 may be used. Set the way to implement when rising. [0040] The agglutination treatment water in the aggregating sensor tank 13 is sent to the solid-liquid separation processing device through the treatment water pump 15. Examples of the solid-liquid separation treatment include a membrane separation treatment, a sand filtration treatment, a precipitation treatment, and a pressurized floating treatment. The method of calculating the amount of addition of the cationic polymer flocculating agent and the inorganic aggregating agent by the titration value obtained by the flow potentiometer 8 can be obtained, for example, from the results shown in FIG. 2 . 2 is a titration curve showing an example of the relationship between the concentration of the cationic polymer flocculating agent and the flow potential value. For example, the concentration (C) required for charge neutralization is a concentration of a cationic polymer flocculant (here, about 5 mg/L) when the flow potential value reaches 0 mV. [0043] The amount of the inorganic aggregating agent to be added depends on the water quality of the water to be treated and the type of the inorganic aggregating agent to be used, but is more than C, preferably 5 to 90 times C (that is, C). It is preferable to adjust the setting in the range of ×5 to C × 90), particularly in the range of 10 to 50 times. The amount of the cationic polymer flocculating agent to be added depends on the water quality of the water to be treated and the type of the cationic polymer flocculating agent to be used, but is less than C, and preferably 0.1 to 0.9 times C (see C). That is, it is preferable to adjust the setting in a range of C × 0.1 to C × 0.9), particularly 0.5 to 0.9 times. 3 is a schematic view showing a configuration of a coagulant injection control device according to another embodiment of the present invention. [0045] The control device of FIG. 3 changes the feedforward control of FIG. 1 to a feedback controller. That is, the sampling tank 6 accommodates a part of the agglomerated water from the aggregating sensor tank 13 so as to return the measured water to the aggregating sensor tank 13. [0046] A flow potentiometer 8 is provided in the sampling tank 6. By using the titration of the same cationic polymer flocculating agent as described above, it is possible to measure an insufficient amount of agglutination which is insufficient from the current amount of drug injection. The sampling tank 6 may be provided to introduce the agglomerated treated water from the collecting tank 11, or may be provided in the latter stage of the solid-liquid separating apparatus to introduce the solid-liquid separating treated water. [0047] The amount of additional addition of the inorganic aggregating agent to the required amount of titration (B) from the charge obtained by the flow potentiometer 8 depends on the quality of the water to be treated and the type of inorganic aggregating agent used. It is preferable to adjust and set the ratio B to be more than 5 to 90 times (i.e., B × 5 to B × 90), preferably in the range of 10 to 50 times B. Further, the additional amount of the cationic polymer flocculating agent depends on the water quality of the water to be treated and the type of the cationic polymer flocculating agent to be used, but it is less than B, and preferably 0.1 to B. It is preferable to adjust and set 0.9 times (that is, B × 0.1 to B × 0.9), preferably in the range of 0.5 to 0.9 times B. [0048] Depending on the water quality of the water to be treated, if the titration value of B is less than 0.1 mg/L, the addition amount of the cationic polymer flocculating agent and the inorganic aggregating agent is in the range of 5% or less. It is advisable to set the method of reduction. 4 is a diagram showing a control device of still another embodiment. In the control device of Fig. 4, the titration device which is not in the sampling tank 6 in the configuration of Fig. 3 must determine the optimum value of the flow potential value of the aggregating treated water by the prior evaluation. In FIG. 4, as in the case of FIG. 3, the sampling tank 6 is provided so that the aggregating treatment water is accommodated by the aggregating sensor tank 13, but the sampling tank 6 may be introduced by the aggregating tank 11 as in the case of FIG. The agglutination treatment water may be provided in the latter stage of the solid-liquid separation device to introduce the solid-liquid separation treatment water. In addition, when introducing the solid-liquid separation treatment water, it is necessary to determine the optimum value of the flow potential value of the solid-liquid separation treatment water by the prior evaluation. [0050] The optimum value of the flow potential value of the agglutination treated water can be determined from the results shown in FIG. 5, for example, to obtain an optimum value. 5 is a graph showing the relationship between the amount of addition of the inorganic aggregating agent and the flow potential value and the quality of the agglomerated treated water, which are evaluated by the previous workbench test, and the water quality of the agglomerated treated water is expressed by the MFF value. The method of measuring the MFF value is as follows. The MF membrane was set in the suction filtration device, and the first time water time T1 of the measurement sample (150 mL) was measured after measuring the permeation time T0 of the soluble polymer substance and the reference water having no fine particles of 150 mL under a reduced pressure of -67 kPa. The second water passing time T2. MFF value = T2 / T1. When the value of MFF is good, the flow potential shows a specific value which is an optimum value (here, about -300 mV) of the flow potential value of the agglomerated water. The correlation diagram between the amount of the inorganic aggregating agent added and the flow potential value as described above is recorded in the aggregation control device, and the inorganic aggregating agent concentration and the flowing potential value indicated by the actual potential value of the agglomerated treated water are optimally set. The difference in the concentration of the agent (here, about 200 mg/L) was used to calculate the insufficient concentration (A) of the inorganic aggregating agent. The additional addition amount of the inorganic aggregating agent depends on the water quality of the water to be treated and the type of the inorganic aggregating agent to be used, but it is 0.1 to 0.9 times of A (that is, A × 0.1 to A × 0.9). It is preferable to adjust and set the mode within a range of 0.2 to 0.5 times of A. In addition, the amount of addition of the cationic polymer flocculant depends on the water quality of the water to be treated and the type of the cationic polymer flocculating agent to be used, and is 0.001 to 0.008 times A (that is, A × 0.001 to A). It is preferable to adjust the setting of ×0.008), preferably in the range of 0.005 to 0.008 times of A. When the flow potential value of the actual aggregating treated water is higher than the optimum value of the flowing potential value of the aggregating treated water, the cationic polymer flocculating agent is likely to be excessive, so the amount of the aggregating agent must be added. Re-evaluation of the set value. [0056] A problem in the on-line measurement of the flow potentiometer 8 in the configuration of FIG. 4 is that the measurement portion of the flow potentiometer 8 is dirty due to turbidity or organic matter contained in the water to be treated, an added aggregating agent, or the like. The absolute value of the flow potential value cannot be measured correctly. Although the method of washing every measurement is considered, the problem that the consumption of the cleaning liquid is increased and the measurement cannot be performed during the cleaning is newly caused. [0057] In order to solve this problem, a method of measuring the flow potential value of the standard liquid and correcting the measured value is shown below. In the standard solution, in order to impart electrical conductivity, a solution in which a low-concentration salt or a pH buffer is dissolved may be used, and a dispersion of polystyrene latex particles or vermiculite particles or the like may be added. The size of the particles is preferably colloidal particles having a particle diameter of several hundred nm or less, so that particle deposition does not occur. [0058] The conversion formula for the correction is as follows. E2=E1×(R2/R1) E1: Flow potential value of agglutination treated water (measured value) [mV] E2: Flow potential value of agglutination treated water (correction value) [mV] R1: Flow potential value of standard solution ( [mV] R2: Flow potential value of standard solution (before or after measurement of flow potential of agglutination treatment water) [mV] [Examples] [Test method] In the following examples The test water to be used and the reagents used in the comparative examples are as follows. Test treated water: biologically treated water for factory drainage (ORP: 100-200 mV) Cationic polymer: poly(diallyldimethylammonium chloride) Inorganic aggregating agent: ferric chloride (38%) Oxidizer: Sodium hypochlorite [Example 1] In the configuration of the aggregating agent injection control system shown in Fig. 1, an oxidizing agent is added to the raw water tank so that the ORP of the raw water tank is in the range of 325 ± 25 mV, and the amount of the aggregating agent is automatically added. The adjustment value was set as follows: Cationic polymer: C × 0.8 [mg / L] Inorganic aggregating agent: C × 8 [mg / L] The agglutination treatment was carried out. The change with time of the MFF value of the obtained agglomerated water was measured. [Comparative Example 1] In the system configuration shown in Fig. 1, the amount of addition of the cationic polymer was 0.5 mg/L, and the amount of the inorganic aggregating agent was formed without performing automatic adjustment of the amount of addition of the aggregating agent. A quantitative injection of 50 mg/L. Others are the same as in the first embodiment. The results of Example 1 and Comparative Example 1 are shown in FIG. 6. The water content of the water to be treated due to the passage of time was changed, and the C value of the drip amount also changed in the same manner. In Comparative Example 1, the water quality of the agglomeration treatment deteriorated together with the fluctuation of the water quality. On the other hand, in Example 1, the amount of addition of the two types of aggregating agents was automatically adjusted based on the C value, and thus the water quality of the agglutination treatment was hardly deteriorated and did not change. [Embodiment 2] In the system configuration shown in Fig. 1, an oxidizing agent is added to the raw water tank so that the ORP of the raw water tank is in the range of 325 ± 25 mV, and the setting value of the automatic adjustment value of the amount of the aggregating agent added is set. Formed as: Cationic polymer: C × 0.2 [mg / L] Inorganic aggregating agent: C × 30 [mg / L] to carry out agglutination treatment. Further, membrane separation treatment (PVDF, pore diameter: 0.02 μm, operating conditions: operating Flux (flux) 4 m/D, backwashing interval: 28 min) was carried out, and the rate of increase in the differential pressure between membranes was measured as a solid-liquid separation treatment in the latter stage of the system. . [Comparative Example 2] In the system configuration shown in Fig. 1, an oxidizing agent was not added to the raw water tank, and aggregation treatment was performed. Others are the same as in the second embodiment. The results of Example 2 and Comparative Example 2 are shown in Table 1. In Example 2, the C value was lower than that of Comparative Example 2 by adding an oxidizing agent to the raw water tank. This is considered to be due to the deterioration of the treated water. Further, the rate of increase in differential pressure was lower in Example 2, and it was found that good agglomeration treated water was obtained. From this, it is clear that even if a flow potentiometer is used to automatically adjust the amount of addition of the two types of agents, if the ORP of the raw water tank is not adjusted to a certain value or more, the aggregation control cannot be sufficiently performed. [Table 1] [Example 3] The membrane separation treatment (PVDF, pore diameter 0.02 μm, operating conditions: operating Flux 2 to 4 m/D, backwashing interval 10 to 28 min) was carried out in the system configuration shown in Fig. 1 as the latter stage of the system. Solid-liquid separation treatment. Further, the turbidity (inter-aggregate turbidity) of the voids of the coagulating particles in the agglomerated water in the continuous flowing water and the differential pressure between the membranes are measured by the light-scattering microparticle sensor provided in the aggregating sensor tank. The relationship between the rate of rise. The results are shown in FIG. It can be seen that if the turbidity between the agglomerates increases, the rate of increase in the differential pressure also becomes high, and a strong correlation is found. The increase in the turbidity between the agglomerates is considered to be due to the fact that the water quality of the treated water changes rapidly and the aggregation is poor, or the water quality of the treated water greatly changes, and the value measured by the flow potentiometer (A, B, The adjustment of the automatic addition amount of the two types of aggregating agents of the type C is not appropriate. Therefore, when the turbidity between the agglomerates increases to a certain value or more, a method of setting the method of automatically adjusting the amount of the aggregating agent added by the measurement of the flow potentiometer or agglutination of two types is considered. The method of adjusting the automatic addition amount of the agent to the new value is reset. As described above, it can be utilized as an alarm sensor for confirming whether or not aggregation failure has occurred by the particle sensor provided in the aggregating sensor tank. The present invention has been described in detail with reference to the particular embodiments of the invention, and various modifications thereof may be made without departing from the spirit and scope of the invention. The present application is based on Japanese Patent Application No. 2017-047570, filed on Mar.

[0071][0071]

1‧‧‧原水槽1‧‧‧ original sink

1a‧‧‧pH調整槽1a‧‧‧pH adjustment tank

2‧‧‧ORP計2‧‧‧ORP meter

3、12‧‧‧pH計3, 12‧‧‧ pH meter

4‧‧‧原水槽藥品注入控制裝置4‧‧‧ Raw water tank medicine injection control device

5、11‧‧‧凝集槽5, 11‧‧‧ agglutination tank

6‧‧‧取樣槽6‧‧‧Sampling tank

7‧‧‧滴定裝置7‧‧‧Titration device

8‧‧‧流動電位計8‧‧‧Flow potentiometer

9‧‧‧閥9‧‧‧ valve

10‧‧‧凝集劑注入控制裝置10‧‧‧ agglutination agent injection control device

13‧‧‧凝集感測器槽13‧‧‧Aggregation sensor slot

14‧‧‧微粒子感測器14‧‧‧Microparticle sensor

15‧‧‧處理水泵15‧‧‧Processing water pump

[0026]   圖1係本發明之實施形態之凝集劑注入控制裝置的構成圖。   圖2係顯示實驗結果的圖表。   圖3係本發明之實施形態之凝集劑注入控制裝置的構成圖。   圖4係本發明之實施形態之凝集劑注入控制裝置的構成圖。   圖5係顯示實驗結果的圖表。   圖6係顯示實驗結果的圖表。   圖7係顯示實驗結果的圖表。1 is a configuration diagram of a coagulant injection control device according to an embodiment of the present invention. Figure 2 is a graph showing the results of the experiment. Fig. 3 is a configuration diagram of a coagulant injection control device according to an embodiment of the present invention. Fig. 4 is a configuration diagram of a coagulant injection control device according to an embodiment of the present invention. Figure 5 is a graph showing the results of the experiment. Figure 6 is a graph showing the results of the experiment. Figure 7 is a graph showing the results of the experiment.

Claims (14)

一種凝集劑注入控制方法,其係在被處理水添加陽離子性高分子凝集劑及無機凝集劑,且進行固液分離的水處理系統中的凝集劑注入控制方法,其特徵為:   測定被處理水、或添加有凝集劑的凝集處理水的流動電位,根據所測定出的流動電位值,求出上述陽離子性高分子凝集劑及無機凝集劑的添加量,且以該添加量添加陽離子性高分子凝集劑及無機凝集劑。A method for controlling agglutination agent injection, which is a method for controlling agglutination agent injection in a water treatment system in which a cationic polymer aggregating agent and an inorganic aggregating agent are added to a treated water and subjected to solid-liquid separation, wherein: the treated water is measured Or a flow potential of the agglomerated water to which the aggregating agent is added, and the amount of the cationic polymer flocculating agent and the inorganic aggregating agent added is determined based on the measured flow potential value, and the cationic polymer is added in the added amount. Aggregating agent and inorganic aggregating agent. 如申請專利範圍第1項之凝集劑注入控制方法,其中,藉由事前試驗,由凝集處理水的流動電位值的最適值與實際的凝集處理水的流動電位值的差,求出無機凝集劑的不足濃度A,   將無機凝集劑的添加量設為a・A,該陽離子性高分子凝集劑的添加量設為b・A,   其中,a=0.1~0.9   b=0.001~0.008。The method for controlling aggregating agent injection according to the first aspect of the patent application, wherein the inorganic aggregating agent is obtained from a difference between an optimum value of a flow potential value of the agglomerated water and a flow potential value of the actual agglomerated water by an ex ante test In the case of the insufficient concentration A, the amount of the inorganic aggregating agent added is a·A, and the amount of the cationic polymer aggregating agent added is b·A, wherein a=0.1 to 0.9 b=0.001 to 0.008. 如申請專利範圍第2項之凝集劑注入控制方法,其中,為了補正所被測定出的凝集處理水的流動電位值的誤差,在凝集處理水的流動電位值的測定前或後,測定標準溶液的流動電位,根據標準溶液的流動電位值,補正實際的凝集處理水的流動電位值而得補正值,且由凝集處理水的流動電位值的最適值與補正值的差,算出無機凝集劑的不足濃度A。In the method of controlling aggregating agent injection according to the second aspect of the invention, in order to correct the error of the flow potential value of the aggregated treated water to be measured, the standard solution is measured before or after the measurement of the flow potential value of the aggregated treated water. The flow potential is corrected by the flow potential value of the standard solution to correct the flow potential value of the actual agglutination treatment water, and the difference between the optimum value of the flow potential value of the agglutination treatment water and the correction value is used to calculate the inorganic aggregating agent. Insufficient concentration A. 如申請專利範圍第3項之凝集劑注入控制方法,其中,以下式進行補正:   E2=E1×(R2/R1)   其中,E1:凝集處理水的流動電位值(實測值)[mV]   E2:凝集處理水的流動電位值(補正值)[mV]   R1:標準液的流動電位值(事前的工作台試驗評估時)[mV]   R2:標準液的流動電位值(凝集處理水的流動電位測定前或後)[mV]。For example, in the method of controlling the agglutination agent injection according to item 3 of the patent application, wherein the following formula is corrected: E2=E1×(R2/R1) wherein E1: the flow potential value of the agglomerated treated water (measured value) [mV] E2: Flow potential value of agglutination treatment water (correction value) [mV] R1: Flow potential value of standard solution (when evaluation of bench test beforehand) [mV] R2: Flow potential value of standard solution (measurement of flow potential of agglutination treatment water) Before or after) [mV]. 如申請專利範圍第1項之凝集劑注入控制方法,其中,將凝集處理水的一部分在測定容器進行取樣來測定流動電位,   藉由滴定,計測所被測定出的流動電位值由負至顯示0的值為止所需的陽離子性高分子凝集劑的添加量B,   將陽離子性高分子凝集劑的追加添加量設為c・B,無機凝集劑的追加添加量設為d・B,   其中,c=0.1~0.9   d=5~90。The method of controlling aggregating agent injection according to the first aspect of the invention, wherein a part of the agglomerated water is sampled in a measuring container to measure a flow potential, and the measured flow potential value is measured by titration to be negative to display 0. The addition amount B of the cationic polymer flocculating agent required for the value is c·B, and the additional addition amount of the inorganic aggregating agent is d·B, wherein c =0.1 to 0.9 d = 5 to 90. 如申請專利範圍第1項之凝集劑注入控制方法,其中,將被處理水在測定容器進行取樣,   藉由滴定,計測所被測定出的流動電位值由負至顯示0的值為止所需的陽離子性高分子凝集劑的添加量C,   將陽離子性高分子凝集劑的添加量設為e・C,無機凝集劑的添加量設為f・C,   其中,e=0.1~0.9   f=5~90。The method of controlling aggregating agent injection according to the first aspect of the invention, wherein the water to be treated is sampled in a measuring container, and the required flow potential value is measured by titration until a value of 0 is displayed. The amount C of the cationic polymer flocculating agent is set to e·C, and the amount of the inorganic aggregating agent added is f·C, where e=0.1 to 0.9 f=5~ 90. 一種凝集劑注入控制裝置,其係在被處理水添加陽離子性高分子凝集劑及無機凝集劑,且進行固液分離的水處理系統中的凝集劑注入控制裝置,其特徵為:   具有:   測定被處理水、或添加有凝集劑的凝集處理水的流動電位的流動電位計;及   根據該流動電位計的計測值,分別求出上述陽離子性高分子凝集劑及無機凝集劑的添加量的算出手段。A flocculant injection control device which is a flocculant injection control device in a water treatment system in which a cationic polymer aggregating agent and an inorganic aggregating agent are added to a treated water and subjected to solid-liquid separation, and has the following features: a flow potentiometer for treating the flow potential of the water or the agglutination treatment water to which the aggregating agent is added; and calculating means for calculating the addition amount of the cationic polymer flocculant and the inorganic aggregating agent based on the measured value of the flow potentiometer . 如申請專利範圍第7項之凝集劑注入控制裝置,其中,前述算出手段具有:   由藉由事前試驗所求出的凝集處理水的流動電位值的最適值與控制流動電位的測定值的差,求出無機凝集劑的不足濃度A的手段;及   將無機凝集劑的添加量設為a・A,該陽離子性高分子凝集劑的添加量設為b・A的手段。The aggregating agent injection control device according to claim 7, wherein the calculation means has a difference between an optimum value of a flow potential value of the agglutination treated water obtained by a prior test and a measured value of the control flow potential. A means for determining the insufficient concentration A of the inorganic aggregating agent; and a method of setting the amount of the inorganic aggregating agent to a·A and adding the cationic polymer aggregating agent to b·A. 如申請專利範圍第8項之凝集劑注入控制裝置,其中,前述算出手段係具有:   在凝集處理水的流動電位值的測定前或後,測定標準溶液的流動電位的測定手段;   根據標準溶液的流動電位值,獲得所被測定出的凝集處理水的流動電位值的補正值的手段;及   由凝集處理水的流動電位值的最適值與補正值的差,算出無機凝集劑的不足濃度A的手段。The aggregating agent injection control device according to the eighth aspect of the invention, wherein the calculating means includes: a measuring means for measuring a flow potential of the standard solution before or after the measurement of the flow potential value of the agglomerated water; a means for obtaining a correction value of the flow potential value of the aggregated treated water to be measured, and a difference between the optimum value of the flow potential value of the aggregated treated water and the correction value, and calculating the insufficient concentration A of the inorganic aggregating agent means. 如申請專利範圍第7項之凝集劑注入控制裝置,其中,具備有:   收容凝集處理水的一部分的測定容器;   被設在該測定容器的前述流動電位計;   藉由滴定,計測該流動電位計的計測值由負至顯示0的值為止所需的陽離子性高分子凝集劑的添加量的手段;及   算出該陽離子性高分子凝集劑的追加添加量為c・B,且算出無機凝集劑的追加添加量為d・B的手段,   其中,c=0.1~0.9   d=5~90。The aggregating agent injection control device according to claim 7, further comprising: a measurement container that houses a part of the agglutination water; a flow potentiometer provided in the measurement container; and the flow potentiometer is measured by titration The measured value is a means for reducing the amount of the cationic polymer flocculating agent required until the value of 0 is displayed; and calculating the additional amount of the cationic polymer flocculating agent to be c·B, and calculating the inorganic aggregating agent The additional addition amount is a means of d·B, wherein c=0.1 to 0.9 d=5 to 90. 如申請專利範圍第7項之凝集劑注入控制裝置,其中,具備有:   收容被處理水的一部分的測定容器;   被設在該測定容器的前述流動電位計;   藉由滴定,計測該流動電位計的計測值由負至顯示0的值為止所需的該陽離子性高分子的添加量C的手段;及   算出陽離子性高分子凝集劑的添加量為e・C,且算出無機凝集劑的添加量為f・C的手段,   其中,e=0.1~0.9   f=5~90。The aggregating agent injection control device according to claim 7, further comprising: a measurement container that accommodates a part of the water to be treated; the flow potentiometer provided in the measurement container; and the flow potentiometer is measured by titration The measured value is a means for reducing the amount C of the cationic polymer required until the value of 0 is displayed; and the amount of the cationic polymer flocculating agent is calculated as e·C, and the amount of the inorganic aggregating agent is calculated. The means of f·C, where e=0.1 to 0.9 f=5 to 90. 如申請專利範圍第7項至第11項中任一項之凝集劑注入控制裝置,其中,具備有用以計測凝集處理水中的凝集團粒間的空隙中的濁度的光散射式微粒子感測器或光遮斷式微粒子感測器。The aggregator injection control device according to any one of claims 7 to 11, further comprising a light scattering type microparticle sensor for measuring turbidity in a void between the coagulation particles in the agglutination treatment water or Light intercepting microparticle sensor. 一種水處理系統,其係具有如申請專利範圍第7項至第12項中任一項之凝集劑注入控制裝置的水處理系統,其特徵為:   具有:將凝集處理水進行固液分離的固液分離手段。A water treatment system having a water treatment system for aggregating agent injection control device according to any one of claims 7 to 12, characterized in that it has a solid solution for solid-liquid separation of agglomerated water. Liquid separation means. 如申請專利範圍第13項之水處理系統,其中,具有:被處理水的ORP值的測定手段;及以被處理水的ORP值成為300mV以上的方式,對被處理水添加氧化劑的添加手段。The water treatment system according to claim 13 which has a method of measuring an ORP value of the water to be treated, and means for adding an oxidizing agent to the water to be treated so that the ORP value of the water to be treated is 300 mV or more.
TW106132882A 2017-03-13 2017-09-26 Method for controlling injection of flocculant, control device, and water treatment system TW201838701A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017047570A JP6406375B2 (en) 2017-03-13 2017-03-13 Flocculant injection control method, control device, and water treatment system
JP2017-047570 2017-03-13

Publications (1)

Publication Number Publication Date
TW201838701A true TW201838701A (en) 2018-11-01

Family

ID=63523895

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106132882A TW201838701A (en) 2017-03-13 2017-09-26 Method for controlling injection of flocculant, control device, and water treatment system

Country Status (3)

Country Link
JP (1) JP6406375B2 (en)
TW (1) TW201838701A (en)
WO (1) WO2018168021A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102497219B1 (en) * 2021-03-29 2023-02-06 부산대학교 산학협력단 Method of remove microplastics

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51164A (en) * 1974-06-21 1976-01-05 Hitachi Plant Eng & Constr Co Jukibutsuhaisuino jokashorihoho
JP3925621B2 (en) * 2001-11-22 2007-06-06 栗田工業株式会社 Water or sludge treatment system
WO2010053051A1 (en) * 2008-11-04 2010-05-14 栗田工業株式会社 Filtration apparatus and water treatment equipment
US9682872B2 (en) * 2012-02-21 2017-06-20 Denny Allen CRISWELL Wastewater treatment system
JP5951423B2 (en) * 2012-09-13 2016-07-13 株式会社東芝 Flocculant injection control method and flocculant injection control system
JP6276138B2 (en) * 2014-08-25 2018-02-07 株式会社東芝 Water treatment system, control device, and water treatment method

Also Published As

Publication number Publication date
JP6406375B2 (en) 2018-10-17
JP2018149495A (en) 2018-09-27
WO2018168021A1 (en) 2018-09-20

Similar Documents

Publication Publication Date Title
Sinha et al. Determining the effectiveness of conventional and alternative coagulants through effective characterization schemes
JP4277831B2 (en) Aggregation apparatus and aggregation method
Wang et al. Effect of aggregate characteristics under different coagulation mechanisms on microfiltration membrane fouling
Wang et al. Insight into the combined coagulation-ultrafiltration process: The role of Al species of polyaluminum chlorides
JP5364298B2 (en) Dispersant-containing water treatment method
JP5420467B2 (en) Flocculant injection amount determination device and flocculant injection amount control system
JP2008068199A (en) Flocculation device and flocculation method
JP2008068200A (en) Flocculation device and flocculation method
JP2017023918A (en) Treatment method of drainage water containing medicine and treatment device of drainage water
TW201838701A (en) Method for controlling injection of flocculant, control device, and water treatment system
JP2010137115A (en) Coagulant injection control method
JP6673390B2 (en) Coagulant addition control method, control device and water treatment system
JP6276138B2 (en) Water treatment system, control device, and water treatment method
JP6269866B1 (en) PH control method by electric conductivity
JP3731454B2 (en) Method for determining amount of coagulant injection and control device for drug injection
JP6699690B2 (en) Flocculant injection controller
TW201945294A (en) Water treatment method and water treatment apparatus
JPWO2016006419A1 (en) Aggregation method and apparatus
JP2012213675A (en) Method of determining addition amount of coagulant and water treatment apparatus
JP2019155283A (en) Chemical addition amount control device and chemical addition amount control method
KR20140115604A (en) Apparatus and method to control the coagulant concentration by using the surface area of particles, and water-treatment equipment and method having the same
JP4331421B2 (en) Aggregation state detector
KR20140059557A (en) Water treating apparatus with means for adjusting injection amount of coagulant and method for adjusting injection amount of coagulant
Cheng et al. Turbidity fluctuation as a measure of floc size in a coagulation pilot study
KR101135596B1 (en) Method and apparatus for automatic control of injection of coagulation agent